LGND - Ligand Pharmaceuticals Non-GAAP EPS of $1.42 beats by $0.76 revenue of $26.4M beats by $0.67M August, 08 2023 05:42 PM Ligand Pharmaceuticals Incorporated 2023-08-08 17:42:33 ET Ligand Pharmaceuticals press release ( NASDAQ: LGND ): Q2 Non-GAAP EPS of $1.42 beats by $0.76 . Revenue of $26.4M (-47.3% Y/Y) beats by $0.67M . For further details see: Ligand Pharmaceuticals Non-GAAP EPS of $1.42 beats by $0.76, revenue of $26.4M beats by $0.67M